FDAnews Drug Daily Bulletin

AstraZeneca Settles Toprol XL Lawsuit for $11 Million

A A
AstraZeneca and affiliates will pay as much as $11 million to settle claims the company violated antitrust and consumer-protection laws by keeping generic versions of the heart drug Toprol XL off the market.
Businessweek